The Broad Institute Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:The Broad Institute Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013269
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation, is a non-profit research organization that meets critical challenges in biology and medicine. The institute transforms medicine by utilizing systematic approaches in biological sciences, to speed up the understanding and treatment of disease. It focuses on the discovery, development and optimization of technological tools that are needed to obtain and analyze massive amounts of genome-related data. The institute’s projects aim to assemble a complete picture of the molecular components of life; define the biological circuits that underlie cellular responses; uncover the molecular basis of major inherited diseases; unearth all the mutations that underlie different cancer types; discover the molecular basis of major infectious diseases, and transform the process of therapeutic discovery and development. Broad Institute is headquartered in Cambridge, Massachusetts, the US.

The Broad Institute Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
The Broad Institute Inc, Medical Devices Deals, 2011 to YTD 2017 11
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
Eisai Enters into Research Agreement with Broad Institute 14
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 15
Broad Institute Genomic Services Partners with Takeda Pharma 16
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 17
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 18
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 19
Eisai Enters into Research Agreement with Broad Institute 20
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 21
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 22
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 23
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 25
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 26
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 27
Licensing Agreements 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 30
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 32
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 34
Evotec Enters into Licensing Agreement with Broad Institute 35
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 36
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 37
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 38
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 39
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 40
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 41
Applied Stemcell Enters into licensing Agreement with Broad Institute 42
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 43
The Broad Institute Inc – Key Competitors 44
The Broad Institute Inc – Key Employees 45
The Broad Institute Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 47
Strategy And Business Planning 47
Oct 10, 2017: Broad Institute launches Merkin Institute for Transformative Technologies in Healthcare 47
Government and Public Interest 48
Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 48
Product News 50
May 18, 2017: Cohen Veterans Bioscience and the Broad Institute’s Stanley Center for Psychiatric Research with PTSD researchers from the Psychiatric Genomics Consortium Announce Initial Findings from Largest Study of Genetic Markers for Post-Traumatic Stress Disorder 50
Other Significant Developments 51
Jul 10, 2017: Broad Institute of MIT and Harvard Joins Discussions to Create Worldwide CRISPR-Cas9 Licensing Pool 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
The Broad Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
The Broad Institute Inc, Deals By Therapy Area, 2011 to YTD 2017 10
The Broad Institute Inc, Medical Devices Deals, 2011 to YTD 2017 11
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Eisai Enters into Research Agreement with Broad Institute 14
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 15
Broad Institute Genomic Services Partners with Takeda Pharma 16
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 17
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 18
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 19
Eisai Enters into Research Agreement with Broad Institute 20
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 21
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 22
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 23
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 25
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 26
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 27
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 30
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 32
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 34
Evotec Enters into Licensing Agreement with Broad Institute 35
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 36
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 37
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 38
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 39
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 40
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 41
Applied Stemcell Enters into licensing Agreement with Broad Institute 42
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 43
The Broad Institute Inc, Key Competitors 44
The Broad Institute Inc, Key Employees 45
The Broad Institute Inc, Other Locations 46
The Broad Institute Inc, Subsidiaries 46

★海外企業調査レポート[The Broad Institute Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Copart Inc (CPRT):企業の財務・戦略的SWOT分析
    Summary Copart Inc (Copart) carries out the provision of auctions and vehicle marketing services. The company offers sales and marketing of early and late model, hybrid, featured and seller certified vehicles. It markets vehicles which include ATVs, exotic and classic cars, boats, dirt bikes, trucks …
  • Anheuser-Busch InBev NVSA (ABI):企業の財務・戦略的SWOT分析
    Anheuser-Busch InBev NVSA (ABI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • New Zealand Post Ltd:企業の戦略的SWOT分析
    New Zealand Post Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Atmos Energy Corp (ATO):企業の財務・戦略的SWOT分析
    Atmos Energy Corp (ATO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Teradyne Inc (TER):企業の財務・戦略的SWOT分析
    Teradyne Inc (TER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Merck KGaA (MRK)-医療機器分野:企業M&A・提携分析
    Summary Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, O …
  • Sherritt International Corp (S):石油・ガス:M&Aディール及び事業提携情報
    Summary Sherritt International Corp (Sherritt) is a natural resources company. It carries out mining and refining activities for the production of nickel and cobalt from lateritic ores with ownership stake in Moa Joint Venture and Ambatovy Joint Venture. The company also explores, develops and produ …
  • Fuji Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Circuit Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Circuit Therapeutics Inc (Circuit Therapeutics) is a biotechnology company that offers discovery and development of transformational therapies. The company holds expertise in optogenetics technology. Its optogenetics allows control of specific neurons and drives their activity. Circuit Thera …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cayenne Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc, is a soft-tissue reconstruction service provider. The company provides knee and shoulder implant products. It offers products such as aperfix femoral, aperfix II tibial, mirror partial knee, cross fix meniscal …
  • Town Centre Securities Plc:企業の戦略・SWOT・財務情報
    Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report Summary Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • MedX Health Corp (MDX):企業の財務・戦略的SWOT分析
    Summary MedX Health Corp (MedX) operates as a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser pr …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Its I'm InTouch provides a secure and easy to use PC remote access softw …
  • Aravive Inc (VSAR):企業の財務・戦略的SWOT分析
    Summary Aravive Inc(Aravive) formerly known as Versartis Inc, is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GH …
  • Latam Airlines Group S.A.:企業の戦略・SWOT・財務分析
    Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report Summary Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Ma …
  • Keyera Corp (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Keyera Corp (Keyera) is a midstream oil and gas company. The company offers services such as processing, storage, transportation and marketing of oil and natural gas. It owns and operates raw gas gathering pipelines and processing plants, which collect and process raw natural gas, remove was …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆